Proxsys Rx

JANUARY 10, 2023

Nobody’s ever put it better than the Association of American Medical Colleges (AAMC): “Congress created the 340B Drug Pricing Program in 1992 to protect safety-net hospitals from escalating drug prices by allowing them to purchase outpatient drugs at a discount from manufacturers. percent to 3.5

Hospitals 52

Hospitals Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

PharmaVoice

JUNE 16, 2025

The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. The 340B Drug Pricing Program has long been a contentious issue for pharma. The 340B Drug Pricing Program has long been a contentious issue for pharma.

Hospitals 214

Hospitals Mail-Order Pharmacies Drug Pricing Pharmaceutical Companies 214

Viseven

JANUARY 13, 2023

Evaluation of drug efficiency on a dedicated market is a complex process that requires HEOR experts to measure multiple indicators to understand the actual market value of the product. So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? What is HEOR Data?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 40

PharmaShots

MAY 15, 2023

Allyson Moellenhoff: Our Drug Discount Management platform supports all the solutions we have built for the stakeholders in our ecosystem. One of those product suites is Kalderos for Manufacturers, a web-based suite of tools for pharmaceutical companies that sits on top of the Drug Discount Management platform.

Drug Pricing 40

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

STAT

DECEMBER 17, 2024

Sanofi has filed a lawsuit accusing the Biden administration of unlawfully preventing the company from changing payment terms to some hospitals that participate in a federal drug discount program, the fourth time a pharmaceutical company has gone to court in recent weeks over such a dispute.

Hospitals 267

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 267

Pharmaceutical Commerce

JUNE 18, 2025

Supporting sterile barrier packaging and supply chain resilience The Madison plant reinforces the TekniPlex Healthcare’s goal of assisting pharma and medical companies, which indirectly includes its downstream partners as well.

Drug Pricing 52

Drug Pricing Packaging Pharmaceutical Companies Pharmaceutical Companies 52

Pharmacy Times

JUNE 23, 2025

This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. Historically, CMS would stack all multisource generic 505(b)(2) drugs under the same J-code, Soefje explained.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmaceutical Commerce

JUNE 9, 2025

Beyfortus cut RSV hospitalizations by up to 83.2% For instance, an immunization program that was executed in Spain using Beyfortus reportedly reduced infant hospitalizations due to RSV by 69.0% For instance, an immunization program that was executed in Spain using Beyfortus reportedly reduced infant hospitalizations due to RSV by 69.0%

Drug Pricing 52

Drug Pricing Vaccines Immunity Immunization 52

STAT

NOVEMBER 11, 2024

that is distrustful of institutions and eager to blame large corporations, including major pharmaceutical companies, for Americans’ poor health. And if Republicans turn to cuts to Medicaid to fund their other priorities, hospitals could get saddled with more uninsured patients. Kennedy Jr.

Hospitals 352

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 352

STAT

NOVEMBER 27, 2024

Bristol Myers Squibb has filed a lawsuit accusing the Biden administration of unlawfully preventing the company from using rebates to pay hospitals that participate in a federal drug discount program, the fourth large pharmaceutical company to attempt such a move in recent weeks.

Hospitals 320

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 320

STAT

DECEMBER 17, 2024

Measures expected to be included would prohibit PBMs from linking their payments to drug prices in Medicare, increase transparency, and regulate how PBMs get paid for drugs by Medicaid programs. Separately, The company informed hospitals and clinics its new payment procedure would begin on Jan.

Packaging 244

Packaging Hospitals Drug Pricing Pharmaceutical Companies 244

Proxsys Rx

AUGUST 16, 2023

“Don’t believe drug companies: 340B is a program worth saving” On Tuesday, August 8, The Hill published a guest editorial (title above) by John Hassell — national director of advocacy at the AIDS Healthcare Foundation (AHF). First, start with presenting drug company-funded research as if it is non-biased. drug market.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Hospitals Drug Pricing Pharmaceutical Companies 52

STAT

JANUARY 17, 2025

Novartis filed a lawsuit accusing the Biden administration of unlawfully preventing the company from changing payment terms to some hospitals that participate in the 340B Drug Discount Program, the latest instance in which a pharmaceutical company has gone to court in recent months over such a dispute.

Drug Pricing 316

Drug Pricing Diabetes Hospitals Pharmaceutical Companies 316

STAT

JUNE 9, 2025

drug costs to prices paid in other countries risks upending Medicaid’s drug rebate program and could hamper the ability of beneficiaries to obtain needed medications , Bloomberg Law explains.   President Trump’s proposal to peg U.S. An executive order would require pharmaceutical companies to match U.S.

Drug Pricing 180

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 180

European Pharmaceutical Review

FEBRUARY 20, 2025

China and India together supply more than 70 percent of APIs used in US drug manufacturing, while Europe remains a key supplier of high-value biologics and specialised medicines. 3 Additionally, tariffs could increase lead times for manufacturing, as companies navigate customs barriers and seek alternative suppliers. References 1.

Drug Pricing 20

Drug Pricing Pharmaceutical Manufacturing Generic Medicine Hospitals 20

Pharmaceutical Technology

JUNE 27, 2025

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The list price for a month’s supply of 2.4mg Wegovy – the drug’s highest does – is $1,350 in the US, whereas the same dose in the UK costs £175.80

Drug Pricing 59

Drug Pricing Compounding Packaging Communication 59

Pharmaceutical Technology

JUNE 10, 2025

Go deeper with GlobalData Reports United States of America (USA) Drug Pricing and Reimbursement Lands. He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceutical companies. Data Insights The gold standard of business intelligence.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunity 52

Pharmaceutical Technology

JUNE 18, 2025

More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceutical companies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US. Give your business an edge with our leading industry insights.

Drug Pricing 52

Drug Pricing Communication Pharmaceutical Companies Pharmaceutical Companies 52